Khaberni - During 2025, artificial intelligence technology in the medical field has offered a variety of advancements, ranging from cancer treatments and neural implants in the brain, to facilitating discoveries related to metabolic diseases and diabetes.
The addition of artificial intelligence in the search for better cancer treatments involves using genetic data, alongside the growth of pharmacogenomics, which studies how genes affect the body's response to drugs.
Artificial intelligence has helped achieve promising results this year with lower doses of immunotherapy drugs (such as ipilimumab for skin cancer).
Brain-Computer Interface
However, a major leap was developed by researchers from Columbia University, New York-Presbyterian Hospital, Stanford University, and the University of Pennsylvania. This involves a single silicon chip implanted in the brain to communicate with the computer, creating a high-bandwidth wireless connection between the brain and any external computer.
According to the "Engineering Columbia" website, this platform is called the Biological Interface System for the Cortical Shell (BISC).
The new brain implant promises a qualitative leap in the interaction between humans and computers and expands the range of treatment options for neurological conditions such as epilepsy, spinal cord injuries, amyotrophic lateral sclerosis, stroke, and blindness, aiding in controlling seizures and restoring motor, speech, and vision functions.
This is achieved by providing a high-output informational link, with minimal surgical intervention, directly from and to the brain.
According to "Science Daily", the essence of this new system lies in its small size and its ability to transfer data at high speeds, where the thickness of the BISC implant is nearly the thickness of a human hair.
Other Medical Fields
Alongside supporting health systems with sophisticated tools for classifying and sorting data, artificial intelligence has provided several achievements to the medical field during 2025:
• Metabolic diseases and diabetes: Discovery of molecules in the gut (like TMA) that enhance insulin sensitivity, new ways to manage diabetes, and the search for new treatments for liver diseases.
• Neuroscience: Identifying new triggers for dementia (GPX4 enzyme mutation) and structural insights for epilepsy treatments.
• Infectious diseases: Ongoing concern about the H5N1 virus (avian influenza) and progress in developing vaccines, such as the National Institutes of Health trial for Lassa fever.
